Skip to content

RGNT REGENTIS BIOMATERIALS LTD

Follow

ORDINARY SHARES (common), issuer CIK 1912966

Filings received so far for Q3 2026: 6 13F filers report a position in RGNT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Rosalind Advisors, Inc.in group Rosalind Advisors, Inc.701,685$1.27M0.41%013F-HRTimelineGroup
Warberg Asset Management LLC58,526$109K0.02%-28,45413F-HRTimeline
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC58,924$107K<0.01%new13F-HRTimelineGroup
JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC43,240$78.3K<0.01%-9313F-HRTimelineGroup
Marex Group Ltdin group Marex Group Ltd29,371$53.2K<0.01%new13F-HRTimelineGroup
UBS Group AGin group UBS Group AG1,246$2.26K<0.01%+81213F-HRTimelineGroup